Spencer David M.

CIK 00016273621 companyHOUSTON, TX

SEC Profile

Transactions

Companies

Filings

CIK

0001627362

Recent Transactions

46 trades

Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2019-02-01+15,000→ 15,000 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2019-01-03−1,562→ 3,125 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-01-03$3.20/sh−589→ 92,470 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-01-03+1,562→ 93,059 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2019-01-02−2,500→ 7,500 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-01-02$3.33/sh−942→ 91,497 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2019-01-02+2,500→ 92,439 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-09-04$7.04/sh−10,000→ 89,939 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-07-18$7.63/sh−40,000→ 99,939 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2018-07-02+42,000→ 42,000 total
Tax Payment
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-01-03$9.79/sh−589→ 139,939 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2018-01-03+1,563→ 140,528 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2018-01-03−1,563→ 4,687 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2018-01-02+18,000→ 18,000 total
Award
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2018-01-02+10,000→ 10,000 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2017-07-10$11.54/sh−10,000→ 138,965 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2017-07-03+26,250→ 26,250 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2017-01-03+11,250→ 11,250 total
Award
BELLICUM PHARMACEUTICALS, INC
Restricted Stock Units
2017-01-03+6,250→ 6,250 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-12-05$20.00/sh−5,000→ 146,082 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-12-01$17.17/sh−2,967→ 153,115 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-12-01$18.04/sh−2,033→ 151,082 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-23$20.19/sh−6,200→ 156,082 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-22$19.68/sh−10,000→ 162,282 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-21$20.04/sh−300→ 172,282 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-20$20.00/sh−100→ 172,582 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-19$20.02/sh−700→ 172,682 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-09-16$20.01/sh−1,700→ 173,382 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-08-15$20.00/sh−1,000→ 175,082 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2016-07-27$15.00/sh−10,000→ 176,082 total
Award
BELLICUM PHARMACEUTICALS, INC
Employee Stock Option (right to buy)
2016-01-04+60,000→ 60,000 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-12-14$2.55/sh+5,000→ 184,559 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-12-14−5,000→ 117,058 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-12-01$22.95/sh−5,000→ 178,600 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-09-21$2.55/sh+5,000→ 183,600 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-09-21−5,000→ 122,058 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-09-11$19.00/sh−5,000→ 178,600 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-07-02$2.55/sh+20,000→ 183,600 total
Exercise/Conversion
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-07-02−20,000→ 127,058 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-06-16$22.82/sh−17,200→ 165,554 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-06-16$23.79/sh−2,800→ 162,754 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-06-16$23.79/sh−2,800→ 163,600 total
Sale
BELLICUM PHARMACEUTICALS, INC
Common Stock
2015-06-16$22.82/sh−17,200→ 166,400 total
Award
BELLICUM PHARMACEUTICALS, INC
Stock Option (right to buy)
2015-02-24+60,000→ 60,000 total
Conversion
BELLICUM PHARMACEUTICALS, INC
Common Stock
2014-12-23+27,225→ 182,754 total
Conversion
BELLICUM PHARMACEUTICALS, INC
Series C Convertible Preferred Stock
2014-12-23−46,284→ 0 total

Companies

BELLICUM PHARMACEUTICALS, INC
Chief Scientific Officer

Recent Filings

Address

C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800

HOUSTON, TX, 77030

View on SEC.gov